Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 16 for:    glutamate antagonist | Parkinson Disease

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients (LID in PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01767129
Recruitment Status : Completed
First Posted : January 14, 2013
Last Update Posted : January 11, 2018
Sponsor:
Collaborator:
Michael J. Fox Foundation for Parkinson's Research
Information provided by (Responsible Party):
Avanir Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2015
Actual Study Completion Date : April 2015
Certification/Extension First Submitted : January 8, 2018